MoneyWorks4Me

Glenmark Life Scienc - Quaterly Results

23 Jan 2024 Evaluate
The revenue zoomed 5.93% to Rs. 5728.04 millions for the quarter ended December 2023 as compared to Rs. 5407.31 millions during the corresponding quarter last year.Net profit stood at Rs. 1187.65  millions  compared to Rs. 1049.93 millions in the corresponding previous quarter,high by 13.12%.The company reported a good operating profit of 1742.47 millions compared to 1520.64 millions of corresponding previous quarter.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202312 202212 % Var 202312 202212 % Var 202303 202203 % Var
Sales 5728.04 5407.31 5.93 17466.17 15399.00 13.42 21612.20 21232.14 1.79
Other Income 16.91 66.08 -74.41 89.11 261.21 -65.89 289.57 147.04 96.93
PBIDT 1742.47 1520.64 14.59 5417.12 4619.84 17.26 6712.50 6307.64 6.42
Interest 3.87 1.60 141.87 11.82 4.28 176.17 5.47 279.62 -98.04
PBDT 1738.60 1519.04 14.45 5405.30 4615.56 17.11 6707.03 6028.02 11.26
Depreciation 131.77 107.63 22.43 389.18 305.77 27.28 420.94 378.77 11.13
PBT 1606.83 1411.41 13.85 5016.12 4309.79 16.39 6286.09 5649.25 11.27
TAX 419.18 361.48 15.96 1286.60 1103.75 16.57 1616.48 1462.01 10.57
Deferred Tax 30.57 29.70 2.93 75.00 70.75 6.01 110.37 85.74 28.73
PAT 1187.65 1049.93 13.12 3729.52 3206.04 16.33 4669.61 4187.24 11.52
Equity 245.05 245.05 0.00 245.05 245.05 0.00 245.05 245.05 0.00
PBIDTM(%) 30.42 28.12 8.17 31.01 30.00 3.38 31.06 29.71 4.55
Peers
Company Name CMP
Sun Pharma. Inds. 1843.05
Dr. Reddys Labs. 1218.00
Cipla 1386.80
Lupin 2062.65
Zydus Lifesciences 1222.90
View more..